To 1000 Gy and back again: a systematic review on dose-response evaluation in selective internal radiation therapy for primary and secondary liver cancer

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

(2021) Hugo Levillain et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The Impact of Radiobiologically-Informed Dose Prescription on the Clinical Benefit of Yttrium-90 SIRT in Colorectal Cancer Patients

(2020) Elliot M Abbott et al.   JOURNAL OF NUCLEAR MEDICINE

Dose-effect relationships of holmium-166 radioembolization in colorectal cancer

(2020) Caren van Roekel et al.   JOURNAL OF NUCLEAR MEDICINE

Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study

(2020) Anne-Laure Hermann et al.   RADIOLOGY

Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial

(2020) Etienne Garin et al.   Lancet Gastroenterology & Hepatology

Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice

(2019) Christoph G. Radosa et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group

(2019) Riad Salem et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure

(2019) Alexander S. Pasciak et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

First evidence for a dose-response relationship in patients treated with 166Ho-radioembolization: a prospective study

(2019) Remco Bastiaannet et al.   JOURNAL OF NUCLEAR MEDICINE

Re: Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma

(2019) Stephan Walrand et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription

(2018) Chi Lai Ho et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prospective Trial Using Internal Pair-Production Positron Emission Tomography to Establish the Yttrium-90 Radioembolization Dose Required for Response of Hepatocellular Carcinoma

(2018) Keith T. Chan et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Hepatocellular Carcinoma Tumor Dose Response following 90 Y-radioembolization with glass microspheres using 90 Y-SPECT/CT based Voxel Dosimetry

(2018) S.Cheenu Kappadath et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment

(2018) Jennifer M.J. Jongen et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

(2018) Hugo Levillain et al.   EJNMMI Research

Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular Carcinoma

(2018) Carole Allimant et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience

(2018) Héloïse Bourien et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Efficacy of Radioembolization with166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study

(2017) Jip F. Prince et al.   JOURNAL OF NUCLEAR MEDICINE

Resin Versus Glass Microspheres for 90 Y Transarterial Radioembolization: Comparing Survival in Unresectable Hepatocellular Carcinoma Using Pretreatment Partition Model Dosimetry

(2017) Axel Van Der Gucht et al.   JOURNAL OF NUCLEAR MEDICINE

Tumor Dose Response in Yttrium-90 Resin Microsphere Embolization for Neuroendocrine Liver Metastases: A Tumor-Specific Analysis with Dose Estimation Using SPECT-CT

(2017) Orapin Chansanti et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Correlation of Technetium-99m Macroaggregated Albumin and Yttrium-90 Glass Microsphere Biodistribution in Hepatocellular Carcinoma: A Retrospective Review of Pretreatment Single Photon Emission CT and Posttreatment Positron Emission Tomography/CT

(2017) Paul Haste et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

(2017) Valérie Vilgrain et al.   LANCET ONCOLOGY

Clinical and imaging-based prognostic factors in radioembolisation of liver metastases from colorectal cancer: a retrospective exploratory analysis

(2017) Kathy P. Willowson et al.   EJNMMI Research

Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases

(2016) A. F. van den Hoven et al.   JOURNAL OF NUCLEAR MEDICINE

A Microdosimetric Analysis of Absorbed Dose to Tumor as a Function of Number of Microspheres per Unit Volume in 90Y Radioembolization

(2016) A. S. Pasciak et al.   JOURNAL OF NUCLEAR MEDICINE

High impact of macroaggregated albumin-based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with90Y-loaded glass microsphere radioembolization

(2016) Etienne Garin et al.   LIVER INTERNATIONAL

PET/MRI of Hepatic 90Y Microsphere Deposition Determines Individual Tumor Response

(2015) Kathryn J. Fowler et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres

(2015) Serkan Demirelli et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology

(2015) C. Chiesa et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types

(2015) Marnix G. E. H. Lam et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Personalized Dosimetry with Intensification Using 90Y-Loaded Glass Microsphere Radioembolization Induces Prolonged Overall Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis

(2015) E. Garin et al.   JOURNAL OF NUCLEAR MEDICINE

PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy

(2015) Yoo Sung Song et al.   MEDICINE

99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with 166Ho-microspheres

(2014) Mattijs Elschot et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Simple Method for Estimating Dose Delivered to Hepatocellular Carcinoma after Yttrium-90 Glass-Based Radioembolization Therapy: Preliminary Results of a Proof of Concept Study

(2014) Nima Kokabi et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective

(2014) Marta Cremonesi et al.   Frontiers in Oncology

Determination of Radiation Absorbed Dose to Primary Liver Tumors and Normal Liver Tissue Using Post-Radioembolization 90Y PET

(2014) Shyam M. Srinivas et al.   Frontiers in Oncology

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept

(2013) E. Garin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic Utility of 90Y Radioembolization Dosimetry Based on Fusion 99mTc-Macroaggregated Albumin-99mTc-Sulfur Colloid SPECT

(2013) M. G. E. H. Lam et al.   JOURNAL OF NUCLEAR MEDICINE

In Vivo Dosimetry Based on SPECT and MR Imaging of 166Ho-Microspheres for Treatment of Liver Malignancies

(2013) M. L. J. Smits et al.   JOURNAL OF NUCLEAR MEDICINE

The Low Hepatic Toxicity per Gray of 90Y Glass Microspheres Is Linked to Their Transport in the Arterial Tree Favoring a Nonuniform Trapping as Observed in Posttherapy PET Imaging

(2013) S. Walrand et al.   JOURNAL OF NUCLEAR MEDICINE

99mTc-Macroaggregated Albumin Poorly Predicts the Intrahepatic Distribution of 90Y Resin Microspheres in Hepatic Radioembolization

(2013) M. Wondergem et al.   JOURNAL OF NUCLEAR MEDICINE

Quantitative Dosimetry for Yttrium-90 Radionuclide Therapy: Tumor Dose Predicts Fluorodeoxyglucose Positron Emission Tomography Response in Hepatic Metastatic Melanoma

(2013) Bree R. Eaton et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres

(2013) Yung-Hsiang Kao et al.   EJNMMI Research

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study

(2012) Vincenzo Mazzaferro et al.   HEPATOLOGY

Quantification of holmium-166 loaded microspheres: Estimating high local concentrations using a conventional multiple gradient echo sequence with S0-fitting

(2012) Gerrit H. van de Maat et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Image-Guided Personalized Predictive Dosimetry by Artery-Specific SPECT/CT Partition Modeling for Safe and Effective 90Y Radioembolization

(2012) Y. H. Kao et al.   JOURNAL OF NUCLEAR MEDICINE

Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results

(2012) E. Garin et al.   JOURNAL OF NUCLEAR MEDICINE

Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study

(2012) Maarten LJ Smits et al.   LANCET ONCOLOGY

Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?

(2011) Stephan Walrand et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres

(2010) Renaud Lhommel et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization

(2010) Ahsun Riaz et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations

(2010) L. Strigari et al.   JOURNAL OF NUCLEAR MEDICINE

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation

(2009) Etienne Garin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING